Nicole Atwood, AGACNP-BC

Advance Practice Nurse
Neurology

    About me

    Nicole Atwood is a Nurse Practioner who specialized in Adult Gerontology Acute Care.  She is board certified by the American Nurses Credentialing Center.  She cares for those with Stroke and Cerebrovascular abnormalities such as aneurysms, arteriovenous malformation and fistula.  She sees patients in the inpatient setting at both Memorial Medical Center and HSHS.  She is a member of several professional organizations including the American Association of Nurse Practitioners, the American Association of Critical Care Nurses and the American Stroke Association. 

    Gender

    Female

    Education & training

    Board Certifications
    Adult Gerontology Acute Care Nurse Practitioner
    Undergraduate Degree
    University of Illinois, Chicago, IL - Masters of Nursing

    Specialties

    Clinical locations

    Locations

    SIU Neurology Clinic

    751 N. Rutledge St. Springfield, IL 62702 Suite 3100
    Mon - Fri: 8:00 am-4:30 pm

    Hospital privileges

    • HSHS St. John's Hospital, Springfield, IL
    • Memorial Health, Springfield IL

    Research

    Research Interests
    Gerontology: the study of the social, psychological and biological aspects of aging. Acute care nurse seeing stroke patients.

    Clinical trials

    Trial
    Neuroscience Institute

    Sleep for Stroke Management and Recovery Trial

    Active recruiting

    The primary goals of this study are to determine whether treatment of obstructive sleep apnea with positive airway pressure starting shortly after accute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event and (2) improves stroke outcomes at 3 months in patients who experienced ischemic stroke.

    Trial
    Neuroscience Institute

    18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

    Trial
    Neurology

    Portola: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    ANNEXa-1 (18-513): This is a randomized, multicenter clinical trial designed to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracerebral hemorrhage within 6 hours of symptom onset (from the baseline scan) and within 15 hours of taking an oral FXa inhibitor (from randomization). The study will use a prospective, randomized, open-label design, as it is unfeasible to blind the Investigator to the treatment assignment given the many potential therapeutic options available under usual care treatment.